Abstract
Ischemic stroke occurs when a blood clot obstructs or narrows the arteries that supply blood to the brain. Currently, tissue plasminogen activator (tPA), a thrombolytic agent, is the only United States Food and Drug Administration (FDA)-approved pharmacologic treatment for ischemic stroke. Despite its effective usage, the major limitation of tPA that stems from its short half-life in plasma (≈5 min) is the potential for increased risk of hemorrhagic complications. To circumvent these limitations, herein, the first proof-of-principle demonstration of a theranostic nanoconstruct system derived from erythrocytes doped with the FDA-approved near-infrared (NIR) imaging agent, indocyanine green, and surface-functionalized with tPA is reported. Using a clot model, the dual functionality of these nanoconstructs in NIR fluorescence imaging and clot lysis is demonstrated. These biomimetic theranostic nanoconstructs may ultimately be effective in imaging and treatment of blood clots involved in ischemic stroke.
References
Jun 17, 2000·Science·P A OldenborgF P Lindberg
Jul 8, 2003·Nature Biotechnology·Juan-Carlos MurcianoVladimir R Muzykantov
Nov 15, 2005·The Journal of Pharmacology and Experimental Therapeutics·Kumkum GangulyJuan-Carlos Murciano
Oct 24, 2007·Biomaterials·Tze-Wen ChungWei-Jain Tsai
Feb 17, 2009·Thrombosis Research·George J ShawChristy K Holland
Apr 1, 2009·Journal of Neurotrauma·Sherman C SteinVladimir R Muzykantov
Jun 22, 2011·Proceedings of the National Academy of Sciences of the United States of America·Che-Ming J HuLiangfang Zhang
Jul 7, 2012·Science·Netanel KorinDonald E Ingber
Mar 5, 2013·Ultrasound in Medicine & Biology·Jonathan T SuttonChristy K Holland
Jul 13, 2013·Scientific Reports·Baharak BahmaniBahman Anvari
Jun 16, 2015·Journal of Thrombosis and Haemostasis : JTH·S AbsarF Ahsan
Jul 1, 2015·Stroke; a Journal of Cerebral Circulation·William J PowersUNKNOWN American Heart Association Stroke Council
Oct 21, 2015·Nature Reviews. Neurology·Jose G Romano, Ralph L Sacco
Feb 16, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Stepan KoudelkaJaroslav Turánek
Apr 9, 2016·Journal of Basic and Clinical Pharmacy·Anroop B Nair, Shery Jacob
Apr 20, 2016·Biomaterials Science·Haijun Zhang
Jun 21, 2016·Scientific Reports·Andrey S DrozdovVladimir V Vinogradov
Jul 26, 2016·Biomedical Optics Express·Jenny T MacBahman Anvari
Dec 3, 2016·Biointerphases·Caterina Minelli, Alexander G Shard
Sep 30, 2017·Stroke and Vascular Neurology·Yi DongQiang Dong
Feb 14, 2015·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Zengchao TangHong Chen
Apr 21, 2016·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Jyh-Ping ChenYunn-Hwa Ma
Citations
Jul 4, 2019·Current Drug Targets·Virna Margarita Martín GiménezWalter Manucha
Mar 7, 2020·Nanoscale Horizons : the Home for Rapid Reports of Exceptional Significance in Nanoscience and Nanotechnolgy·Joon Ho ParkLiangfang Zhang
Aug 21, 2019·Journal of Biomedical Optics·Taylor HanleyBahman Anvari
May 14, 2020·Pharmaceutics·Bridget E Bax
Jan 1, 2021·Drug Discovery Today·Waleed H AlmalkiWenzhi Zhang
Feb 2, 2021·Drug Delivery·Hongyin MaZhen-Ni Guo
Sep 19, 2020·Advanced Drug Delivery Reviews·Flávia CastroBruno Sarmento
Aug 21, 2020·Biomaterials·Alina ZenychCédric Chauvierre
May 25, 2021·Frontiers in Molecular Biosciences·Kenneth S Hettie
Jun 3, 2021·Pharmaceutics·Clara Correa-PazFrancisco Campos
Jun 3, 2021·Biomolecules·Taylor HanleyBahman Anvari
Jun 10, 2021·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Maxim A ZakharzhevskiiVladimir V Vinogradov